Prof. Dr. Joshua Lo: "Our mission goes beyond business; we are building a life-saving platform that benefits patients, investors, valuable asset owners, employees, and society at large. By integrating cutting-edge precision health technologies with global capital markets, and strategically driving asset injection through non-cash contributions (Sachkapitalerhöhung), we aim to create sustainable value and improve lives worldwide."
In compliance with German Corporate Law (§§ 27–33 AktG), we uphold the highest standards of transparency in valuation and disclosure, ensuring trust and accountability in every step.
📸 Prof. Dr. Joshua Lo at the Frankfurt Stock Exchange, symbolizing our commitment to bridging innovation and financial excellence for global impact.
